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ABBREVIATIONS 
 
BCR, B cell antigen receptor 
TLR, Toll-like receptor 
NF, nuclear factor 
FcRIIB, Fc receptor type IIB 
ODN, oligodeoxynucleotide 
Pam3CSK4, S-[2,3-Bis(palmitoyloxy)-(2-RS)-propyl]-N-palmitoyl-(R)-Cys-(S)-Ser-(S)-Lys4-OH 
PMA, phorbol 12-myristate 13-acetate. 
 4 
 
SUMMARY 
 
IB- is a nuclear IB protein robustly induced in macrophages and fibroblasts upon Toll-like 
receptor (TLR) or IL-1 receptor stimulation. IB- associates with nuclear factor-B in the cell nucleus and 
is essential for the induction of a subset of secondary response genes represented by IL-6. Here I analyzed 
induction of IB- in mouse B cells and found that IB- is induced by B cell antigen receptor (BCR) or 
TLR stimulation. Similar to TLR stimulation, BCR stimulation elicited nuclear factor-B-mediated 
transcriptional activation and mRNA stabilization of IB- via a cis-element in IB- mRNA. Proteasome 
inhibitors inhibited transcriptional activation, but not post-transcriptional activation, indicating 
independency of the two signals. Co-stimulation of BCR and TLR9, but not TLR2/1, synergistically induced 
IB-. Co-engagement of inhibitory Fc receptor suppressed BCR-mediated IB- expression, but not that 
induced by TLR stimulation alone or co-stimulation of TLR and BCR. The PI3K inhibitor LY294002 
inhibited BCR-mediated, by not TLR-mediated, induction of IB-, consistent with the role of PI3K in BCR 
signaling and its suppression by Fc receptor. Analysis of IB--deficient B cells demonstrated that IB- 
was essential upon stimulation of BCR or TLR for the expression of several genes including IL-10 and 
cytotoxic T-lymphocyte-associated protein 4. Strict regulatory mechanisms for the induction of IB- via 
multiple pathways and its essential function for gene expression upon stimulation strongly suggest that 
IB- plays an important role in B cell functions. 
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PREFACE 
 
The mammalian host immunity is comprised of two types of systems: innate and adaptive immunity. The 
innate immune system is the first line of host defense. The innate immune cells recognize pathogens via 
germ-line encoded pathogen receptors, such as Toll-like receptors (TLRs). In contrast, the adaptive immune 
system is characterized by antigen-specificity, which is clonally selected from large repertoires of antigen 
receptors. This selection is done via a mechanism generally known as gene rearrangement. 
B cells are key players in humoral immunity. B cells recognize invaded pathogens by both B cell antigen 
receptor (BCR) and TLRs and remove them via antibody secretion, antigen presentation, and cytokine 
production. A critical role for B cells in host immunity is exemplified by X-linked agammaglobulinaemia 
patients, who do not generate mature B cells and exhibit increased susceptibility to infection. However, 
abnormal activation of B cells against self-derived materials results in induction of autoimmune diseases. For 
example, complexes of nucleic acid and anti-nuclear autoantibody bind to both BCR and TLR, which elicit 
strong B cell activation against self. These abnormally activated B cells produce more autoantibodies. These 
autoantibodies are deposited in various tissues and promote tissue damages via interactions with the 
complement systems. Thus, the elucidation of B cell activation mechanism via TLR and BCR is required for 
understating of host defense and autoimmunity.  
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INTRODUCTION 
 
In addition to BCR, B cells express germ-line encoded pathogen receptors, such as TLRs. Recognition of 
pathogen-derived molecules via TLRs in conjunction with BCR, induces proliferation, differentiation and 
production of cytokines and antibodies (1). Both BCR- and TLR-mediated responses induce activation of nuclear 
factor (NF)-B, a nuclear factor that binds to the enhancer region of Ig  light chain (2), and which acts as a key 
regulator of B cell development, survival, and functions (3). NF-B activation by stimulation of TLRs and other 
innate pathogen receptors is essential for the induction of numerous inflammatory genes (4). NF-B plays 
important roles not only in inflammation but also in various important biological processes such as embryonic 
development, cell differentiation and stress responses. Molecular studies of NF-B activation have established a 
role for cytosolic IB proteins such as IB-, -, or -, that associate with NF-B. Phosphorylation-dependent 
degradation of cytosolic IB proteins allows nuclear translocation of NF-B, where it activates transcription. 
However, the precise mechanisms that ensure selective activation of appropriate genes in response to specific 
stimuli by this multifunctional transcription factor remain to be elucidated, but may include cell context-dependent 
chromatin structures, combinations of different NF-B subunits or other transcription factors, and specific 
modifications of NF-B. Recent studies indicated a critical role for NF-B binding proteins or co-factors in 
specific gene induction (5). 
Nfkbiz was originally identified as a gene induced in macrophages by LPS (6). Its product is a nuclear 
IB protein, IB-, harboring ankyrin repeats that associate with NF-B. In contrast to cytosolic IB proteins, 
IB- is exclusively localized in the nucleus and does not affect nuclear translocation of NF-B (6). IB- is 
induced upon receptor stimulation and modulates NF-B activity in the nucleus, allowing chromatin remodeling 
essential for the induction of genes such as IL-6 in response to LPS (7-9).  
In addition, IL-1 and TLR agonists other than LPS can induce IB- in macrophages or fibroblasts (6). 
Its induction requires NF-B-mediated transcriptional activation (10) and post-transcriptional activation including 
specific mRNA stabilization (11), both of which are stimulated by MyD88-dependent signaling. A 165-nt element 
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in the 3'-UTR of IB- mRNA acts as a cis-element that controls post-transcriptional regulation (12). Upon 
stimulation of TLR or IL-1 receptor, IRAK1 together with TRAF6 activates the post-transcriptional mechanism 
(13). Interestingly, TNF-, another potent proinflammatory cytokine, activates NF-B-mediated transcriptional 
activation but does not elicit post-transcriptional activation, resulting in failure of IB- induction (11). 
Recent studies have demonstrated that IB- functions in innate and adaptive immunity. For instance, 
IB- is critical for Th17 cell differentiation and natural killer cell activation (14, 15). In addition, It was shown 
that IB- is induced in B cells upon BCR stimulation (16). Here, I show that either BCR or TLR stimulation of B 
cells elicits IB- induction via transcriptional and post-transcription activation. Interestingly, BCR-mediated 
signaling is inhibited by Fc receptor type IIB (FcRIIB) co-engagement and co-stimulation of BCR and TLR9 
synergistically augments IB- induction. Fine-tuning of IB- induction via multiple regulatory mechanisms 
suggests its significance in B cell functions. 
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EXPERIMENTAL PROCEDURES 
 
Reagents ― Goat F(ab')2 fragment of anti-mouse IgM was purchased from Jackson ImmunoResearch 
Laboratories, Inc. (West Grove, PA). Rabbit IgG and F(ab')2 fragment of anti-mouse IgG were from Millipore Inc. 
(Bedford, MA). Rat anti-mouse FcRII/III monoclonal antibody 2.4G2 was obtained from BD PharMingen™ (San 
Diego, CA). LPS from Escherichia coli O111:B4 was purchased from List Biological Laboratories Inc. (Campbell, 
CA). A phosphorothioate-stabilized CpG oligodeoxynucleotide (ODN1826, 5′-TCCAT GACGT TCCTG 
ACGTT-3′) was synthesized by Sigma-Genosys Japan K.K. (Ishikari, Japan). S-[2,3-Bis(palmitoyloxy)-(2-RS)- 
propyl]-N-palmitoyl-(R)-Cys-(S)-Ser-(S)-Lys4-OH (Pam3CSK4) was synthesized by Peptide Institute, Inc. (Osaka, 
Japan). Phorbol 12-myristate 13-acetate (PMA) and ionomycin were purchased from Sigma-Aldrich Japan K.K. 
(Tokyo, Japan). MG-132, lactacystin, and LY294002 were from Calbiochem (San Diego, CA). SCADS inhibitor 
kit containing approximately 300 inhibitors was provided by Screening Committee of Anticancer Drugs supported 
by Grant-in-Aid for Scientific Research on Priority Area "Cancer" from The Ministry of Education, Culture, 
Sports, Science and Technology, Japan. Anti-IB- monoclonal antibodies were raised against a bacterially 
expressed recombinant mouse IB- protein in rats. Anti--actin antibody was purchased from Abcam 
(Cambridge, UK). Anti-rabbit IgG and anti-rat IgG antibodies conjugated with HRP were from Merck Millipore 
(Billerica, MA). Blasticidin S was obtained from Kaken Pharmaceutical Co., Ltd. (Tokyo, Japan). Hygromycin and 
G418 were from Nacalai Tesque, Inc. (Kyoto, Japan). 
Plasmids ― Reporter plasmids for the IB- promoter, pNfkbiz(-1,725)-Luc, pNfkbiz(-786)-Luc, 
pNfkbiz(-786(B1M))-Luc, pNfkbiz(-786(B2M))-Luc, pNfkbiz(-786(B3M))-Luc, the 165-nt element-mediated 
post-transcriptional regulation (pGL4.12-SV40-[luc2CP]-Nfkbiz-Full, -Reverse, -After pA, -3'-UTR, and -165nt), 
and the NF-B reporter pELAM1-Luc were described previously (11, 12, 17). pTet-off and pTRE2-Hyg-Luc were 
purchased from Clontech Laboratories, Inc. (Mountain View. CA). pEF6/V5-His A was from Invitrogen Corp. 
(Carlsbad, CA). The pEF-Tet-off plasmid was constructed by subcloning the tet repressor cDNA between the 
BamHI and EcoRI sites downstream of the elongation factor-1 promoter in pEF6/V5-His A. The 
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pTRE2-Hyg-Luc-Nfkbiz-3'-UTR plasmid was constructed by subcloning the 3'-UTR region of IB- mRNA into 
the EcoRV site downstream of the luciferase open reading frame in pTRE2-Hyg-Luc. 
Cells ― The murine B lymphoma cell line A20 and the FcRIIB-negative mutant cell line IIA1.6 
derived from A20 (18) were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated FCS, 100 
U/ml penicillin, 100 g/ml streptomycin, 2 mM L-glutamine, 0.1 mM non-essential amino acids, 1 mM sodium 
pyruvate, and 50 M 2-mercaptoethanol at 37C in 5% CO2. The murine macrophage cell line RAW264.7 and a 
stable RAW264.7 line transfected with pELAM1-Luc (19) were maintained in DMEM with 10% heat-inactivated 
FCS, 100 U/ml penicillin, 100 g/ml streptomycin. Splenocytes from Balb/c mice were maintained in RPMI 1640 
medium supplemented with 10% heat-inactivated FCS, 100 U/ml penicillin, 100 g/ml streptomycin, and 50 M 
2-mercaptoethanol at 37C in 5% CO2. B cells were purified from the spleen of IB--deficient mice (7) or wild 
type littermate control mice by negative depletion of cells expressing CD43, CD4 or Ter-119 using a B cell 
isolation kit (Miltenyi Biotech, Bergisch Gladbach, Germany) according to the manufacturer’s protocol, resulting 
in purity > 95% of B220
+
 B cells. Mice were maintained under specific pathogen-free conditions in the animal 
facilities of Tohoku University. Animal experiment protocols were approved by the Institutional Animal Care and 
Use Committee. 
Northern Blot Analysis ― Total RNA was extracted using RNAiso plus (Takara Bio Inc., Otsu, Japan) 
and subjected to Northern blot analysis with a [
32
P]-labeled probe for IB-, IB-, or -actin. Hybridized bands 
were visualized and quantified by phosphor imaging with FLA-3000 (FujiFilm Corp., Tokyo, Japan). 
Real-time RT-PCR ― Total RNA was prepared using RNAiso plus. mRNA levels were quantified by 
real time RT-PCR with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) 
and SYBR Premix EX Taq II (Takara Bio Inc.) using a LightCycler 3302 (Roche Diagnostics GmbH, Mannheim, 
Germany). The primer sequences used are shown in Supplemental Table 1. 
Immunoblotting ─ Cells were lysed, subjected to 10% SDS-PAGE, and analyzed by immunoblotting 
with anti-IB- or anti--actin antibodies and secondary antibodies conjugated with horseradish-peroxidase. 
Bound antibodies were visualized by chemiluminescence following incubation with Immobilon Western 
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Chemiluminescent HRP Substrate (Merck Millipore). 
Transfection ― A20 cells were transfected by electroporation with the indicated reporter plasmid and 
pEF6/V5-His A at a ratio of 19:1. One day after electroporation, cells were selected with 5 g/ml blasticidin S for 
10-11 days and used for stimulation. To obtain reporter stable cell lines, transfected cells were cloned by limiting 
dilution following selection. A20 Tet-off cells were obtained by transfecting A20 cells with pEF-Tet-off, followed 
by selection with 5 g/ml blasticidin S and cloning. A20-Tet-off cells were transfected with pTRE2-Hyg-Luc, and 
selected with 750 g/ml hygromycin for 2 weeks and cloned. RAW264.7 cells were transfected with 
pGL4.12-SV40-[luc2CP]-NFkbiz-165nt and pcDNA3 at a ratio of 19:1 using HilyMax (Dojindo Laboratories, 
Kumamoto, Japan), selected with 1 mg/ml G418, and cloned. 
Luciferase Assay ― Cells at 4  10
6
 cells/ml were stimulated as indicated and lysed for luciferase assay. 
Luciferase activity was measured by the Single-Luciferase Reporter Assay System according to the manufacturer’s 
instructions (Promega Corp., Madison, WI). 
ELISA ― ELISA for IL-10 (PeproTech Inc., Rocky Hill, NJ) and TNF- (Invitrogen) were performed 
according to the manufacturer’s instructions. 
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RESULTS 
 
IB- Is Induced by BCR and TLR Stimulation of B Cells ― To examine IB- induction in response to 
BCR engagement, mouse splenocytes were stimulated with F(ab')2 fragment of anti-Ig antibody. Northern blot 
analysis revealed that IB- mRNA was barely detectable in unstimulated splenocytes, but was robustly induced 
in response to the TLR4 ligand LPS or PMA/ionomycin 1 h after stimulation (Fig. 1A). Upon BCR stimulation 
with anti-IgM antibody the induction of IB- mRNA was observed in primary splenic B cells. IB-, an NF-B 
target gene, was also induced by anti-IgM antibody or LPS. As in splenic B cells, induction of IB- and IB- 
mRNA was observed in A20 B cell lymphoma upon stimulation with anti-IgG F(ab')2 or with CpG ODN, a TLR9 
ligand, indicating that IB- can be induced by either BCR or TLR stimulation (Fig. 1, B and C). 
In contrast to F(ab')2 stimulation, BCR engagement by intact IgG of anti-Ig elicited marginal IB- 
induction and no IB- induction in A20 cells (Fig. 1, B and C). In a FcRIIB-deficient cell line (IIA1.6), similar 
levels of IB- or IB- mRNA induction were observed by stimulation with the intact IgG of anti-Ig or F(ab')2 
fragments (Fig. 1A). Thus, suppression was caused by co-crosslinking of FcRIIB and BCR via the Fc region of 
the antibody (20). 
Induction of IB- protein was detected 1 h after BCR stimulation with F(ab')2 and peaked at 2 h (Fig. 
1D). Co-engagement of FcRIIB abolished this induction. Compared with BCR engagement, TLR9 stimulation by 
CpG ODN elicited greater induction at 2 h after stimulation, which further increased at 4 h. 
BCR Stimulation Elicits Transcriptional and Post-transcriptional Activation of IB- ― Induction of 
IB- mRNA in LPS-stimulated macrophages requires NF-B-mediated transcriptional activation of IB- (10, 
11). I therefore analyzed activation of the IB- promoter by reporter analyses. Upon stimulation of A20 cells with 
F(ab')2 of anti-Ig antibody, a reporter harboring an IB- promoter fragment from −1,725 to +115 bp was 
significantly activated similar to the NF-B reporter pELAM1-Luc (Fig. 2A). A further truncated IB- promoter 
from −786 bp was also activated in response to BCR engagement (Fig. 2B). This promoter region contains three 
NF-B binding sites, B1, 2 and 3. Introduction of mutations at the B2 site severely impaired activation in 
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response to BCR engagement as in LPS stimulated macrophages (11), indicating a critical role for NF-B in the 
transcriptional activation. Mutations at the B1 site moderately reduced activation, but mutations at the B3 site, 
whose sequence is not conserved between mouse and human, did not affect activation. 
In addition to transcriptional activation, post-transcriptional activation mediated via the 165-nt element 
in the 3'-UTR of IB- mRNA is critically involved in IB- induction in response to LPS or IL-1 (11, 12). 
Post-transcriptional activation was quantitatively analyzed using SV40 promoter-driven reporters that expressed a 
fusion mRNA for luciferase followed by IB- mRNA (Fig. 3A) (12). Addition of the IB- mRNA sequence to 
luciferase mRNA resulted in suppressed expression of luciferase activity in unstimulated A20 cells (Fig. 3B, Full). 
Luciferase activity, however, was stimulated upon BCR engagement with F(ab′)2 of anti-Ig (Fig. 3C). These 
effects were not observed when the IB- sequence was placed in the reverse orientation (Fig. 3, A-C, Reverse). 
Furthermore, the effects were abolished when the IB- sequence was inserted downstream of the poly A signal so 
that the inserted sequence was not transcribed (Fig. 3, A-C, After pA). These results indicate that the IB- mRNA 
sequence is acting as an orientation-specific cis-element in mRNA, rather than an enhancer element. The fusion 
mRNA harboring only 3'-UTR or the 165-nt element of IB- mRNA also exhibited the similar expression (Fig. 3, 
D and E), indicating that the 165-nt element in the 3'-UTR acts as a critical cis-element for the post-transcriptional 
regulation in BCR-mediated induction of IB-. A 168 nucleotide fragment of chicken IB- mRNA, homologous 
to the mouse 165-nt element, also acted as a cis-element for post-transcriptional activation upon BCR stimulation 
of the chicken B cell line DT40 (data not shown), indicating a conserved mechanism across the species. 
Post-transcriptional regulation is mainly controlled by mRNA stability and translational efficiency. To 
evaluate mRNA stability of target mRNAs without possible cytotoxic effects of general transcriptional inhibitors 
such as actinomycin D, I established an A20 cell line constitutively expressing the tetracycline-controlled 
transcriptional transactivator (A20-Tet-off). A20-Tef-off cells were transfected with a plasmid containing the 
fusion luciferase mRNA with or without the 3'-UTR of IB- mRNA under the control of a 
tetracycline-responsive promoter. Following addition of doxycycline that specifically turned off transcription of 
target mRNAs, mRNA decay was quantitatively analyzed. Luciferase mRNA slowly decayed and its stability did 
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not change upon BCR engagement with F(ab')2 (Fig. 4A). The fusion luciferase mRNA harboring the 3'-UTR of 
IB- exhibited lower stability, but was stabilized upon BCR stimulation to the level of the control luciferase 
mRNA without the element (Fig. 4B). 
Transcriptional and Post-transcriptional Activation of IB- Is Independently Regulated ― I next 
examined whether transcriptional and post-transcriptional activation of IB- were coordinated upon stimulation. 
MG-132, a proteasome inhibitor, dose-dependently suppressed BCR-mediated activation of the ELAM1 reporter, 
indicating inhibition of NF-B (Fig. 5A). Similarly, transcriptional activation of the IB- promoter was also 
suppressed by the inhibitor. In contrast to transcriptional activation, post-transcriptional activation of IB- was 
not inhibited, but rather enhanced by MG-132 treatment. Similar results were obtained with another proteasome 
inhibitor, lactacystin. NF-B activation by stimulation of TLR4 with LPS in macrophages was also inhibited by 
either MG-132 or lactacystin (Fig. 5B). Post-transcriptional activation by TLR4 stimulation was slightly 
up-regulated in the presence of these inhibitors as BCR-induced activation (Fig. 5C). 
Co-engagement of FcRIIB and BCR Suppresses Transcriptional and Post-transcriptional activation of 
IB- ― Because co-engagement of FcRIIB with BCR inhibited IB- mRNA induction as shown in Fig. 1, I 
analyzed the effect of co-engagement of FcRIIB on the transcriptional and post-transcriptional activation of IB-. 
BCR-mediated activation of the ELAM1 promoter in F(ab')2-stimulated cells was significantly inhibited upon 
co-engagement of FcRIIB and BCR by intact IgG of anti-Ig, demonstrating efficient NF-B suppression (Fig. 6A). 
FcRIIB co-engagement similarly inhibited activation of the IB- promoter as expected. Likewise, stabilization 
of mRNA harboring 3'-UTR of IB- mRNA upon BCR stimulation was not observed using intact IgG, indicating 
suppression by the co-engagement of FcRIIB and BCR (Fig. 6B). Thus, stimulation with F(ab')2 of anti-Ig, but not 
intact IgG, specifically up-regulated activity of the reporter harboring the 165-nt element (Fig. 6, C and D). 
Following pre-treatment with the anti-FcRIIB antibody 2.4G2, stimulation with intact IgG elicited 
post-transcriptional activation, further indicating that suppression was mediated by FcRIIB. 
BCR and TLR9 Synergistically Activate IB- Induction ― Because BCR and TLR independently 
elicited transcriptional and post-transcriptional activation of IB-, I examined IB- induction following 
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co-stimulation of the two types of receptors. IB- mRNA was induced by BCR stimulation with F(ab')2 fragment 
of anti-Ig or by TLR9 stimulation with CpG ODN, and the induction level was not affected by co-stimulation of 
BCR and TLR9 in A20 cells (Fig. 7A). In contrast to IB-, induction of IB- mRNA was robustly enhanced by 
co-stimulation of BCR and TLR9 (Fig. 7B). The synergistic induction of IB- mRNA was not observed with 
TLR2/1 stimulated with a lipopeptide (Pam3CSK4) (Fig. 7, C and D), indicating a TLR9-specific effect. Enhanced 
induction of IB-, but not IB-, by co-stimulation of BCR and TLR9 was also observed in purified splenic B 
cells (Fig. 7, E and F). 
Furthermore, I determined whether co-engagement of FcRIIB inhibited TLR-mediated induction of 
IB-. Co-stimulation with F(ab')2 fragment and intact IgG of anti-Ig, did not elicit either IB- or IB- mRNA, 
indicating suppression of BCR-mediated induction (Fig. 7, A-F). When cells were co-stimulated with CpG ODN 
or Pam3CSK4 and intact IgG, neither IB- mRNA nor IB- mRNA induction was suppressed by intact IgG 
stimulation (Fig. 7, A-F). Notably, CpG ODN and intact IgG co-stimulation elicited robust induction of IB- 
mRNA to the levels observed for synergistic induction by CpG ODN and F(ab')2 fragment. The synergistic 
induction of IB- mRNA in A20 cells by BCR and TLR9 was reflected in the protein expression levels (Fig. 7, G 
and H). The synergistic induction of IB- mRNA in splenic B cells was weaker than that observed in A20 cells, 
but robust induction of IB- was elicited at the protein levels by co-stimulation with CpG DNA and either F(ab')2 
fragment or intact IgG of anti-Ig. Thus, the co-engagement of FcRIIB specifically inhibits BCR-mediated 
induction, but not TLR-mediated induction of IB- or the synergistic induction. 
I next explored the relationship between BCR- and TLR-mediated induction of IB- and its suppression 
by FcRIIB. After screening approximately 300 inhibitors, I focused on inhibitors of PI3K, which is critical in 
BCR-signaling (21) and is suppressed by FcRIIB co-engagement. The PI3K inhibitor LY294002 
dose-dependently inhibited BCR-mediated induction of IB- mRNA, but not TLR-mediated induction (Fig. 7, I 
and J). 
IB- Regulates Gene Expression in Activated B Cells ― To evaluate the significance of IB- 
induction upon B cell activation, I examined gene expression in B cells from IB--deficient mice. While 
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induction of mRNAs for LIM domain containing protein Ajuba (Jub) (22) and the junction adhesion molecule 2 
(Jam2) (23) was impaired 24 h after BCR stimulation, induction of the C-type lectins Clec4d (24) and Clec4e (also 
known as Mincle) (25) were markedly up-regulated (Fig. 8A). Following TLR9 stimulation, expression of FcRIIB, 
CD72, and CD22 were reduced in IB--deficient B cells 4 h after TLR9 stimulation (Fig. 8B). In addition, 
induction of IL-10 mRNA was abolished in IB--deficient B cells (Fig. 8C). On the other hand, significantly 
up-regulated TNF- mRNA expression was observed at 24 h after TLR9 stimulation in B cells lacking IB as in 
TLR-stimulated IB--deficient macrophages (7, 8). I also found that mRNA for cytotoxic 
T-lymphocyte-associated protein 4 (Ctla4) was synergistically induced upon co-stimulation of BCR and TLR9 in 
wild type B cells, but not in IB--deficient B cells. Consistent with the mRNA expression levels, IL-10 
production upon TLR9 stimulation was abolished in IB--deficient B cells and TNF- production was enhanced 
(Fig. 8D). TNF- production upon BCR stimulation was unaffected in IB--deficient cells. TNF- expression 
was further enhanced by co-stimulation with CpG ODN and F(ab′)2 of anti-Ig. 
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DISCUSSION 
 
IB- was originally identified in macrophages as a molecule induced by TLR stimulation, but is also 
induced in B cells by BCR or TLR stimulation. The present study demonstrated that BCR engagement induces 
both NF-B-mediated transcriptional activation and post-transcriptional activation via the 165-nt element in IB- 
mRNA, similar to that of TLR or IL-1 stimulation in macrophages or fibroblasts. mRNA stability analysis 
indicated that the 165-nt element acts as a cis-element to destabilize mRNA. Upon BCR stimulation, stability of 
mRNA with the 165-nt element was recovered to levels seen in the absence of the element, indicating relief from 
destabilization. 
The proteasome inhibitors lactacystin and MG-132 inhibited transcriptional activation of the IB- 
promoter but not the post-transcriptional activation of IB- mRNA. Thus, the signaling pathway involved in 
post-transcriptional activation does not depend on transcriptional activation, which requires NF-B activation. 
Rather, both inhibitors enhanced post-transcriptional activation, suggesting a negative effect by degradation of the 
signaling components. 
Although both BCR and TLR stimulation induced IB-, sensitivity to PI3K inhibitors revealed distinct 
signaling pathways. PI3K is required for BCR-induced NF-B activation, but not that induced by TLRs (26). 
Activation of PI3K-Akt signaling causes phosphorylation of the RNA binding protein KSRP, which stabilizes 
target mRNAs (27), and KSRP binds to various mRNAs for inflammatory proteins including IB- (28). 
Previously It was demonstrated that TLR- or IL-1-induced activation of the post-transcriptional regulation of 
IB- is mediated by IRAK1 and TRAF6 downstream of MyD88 (13). Although downstream mediators may be 
common to the activation pathways, the receptor-proximal events are different between BCR and TLR. 
Increased mRNA stability and translational efficiency are two important mechanisms for 
post-transcriptional regulation. The degree of mRNA stabilization containing the 165-nt element was comparable 
to the up-regulation of reporter activity with the element. Therefore, mRNA stabilization accounts for most of the 
post-transcriptional activation of IB- upon BCR stimulation, in contrast to IL-1 induction of IB-, which 
 17 
 
modulates mRNA stability and translational efficiency via the 165-nt element (11, 12, 29). IB- protein 
expression by TLR9 stimulation was greater than that induced by BCR engagement although both elicited 
comparable levels of mRNA induction, consistent with the notion that translation of IB- mRNA was specifically 
up-regulated by TLR9 stimulation. 
Although induction of IB- by BCR stimulation alone was weak, co-stimulation of BCR and TLR9 
synergistically elicited robust IB- induction in A20 cells and splenic B cells. Co-stimulation of BCR and TLR9 
can synergistically activate NF-B and enhance proliferation and antibody production (30, 31). The synergy of 
IB- mRNA induction by TLR9 and BCR stimulation was less prominent in splenic B cells when compared with 
that in A20 cells. The reason for this quantitative difference is currently unknown, but as A20 cells express surface 
IgG, the signaling pathways of naïve B cells expressing surface IgM may be modulated following initial 
stimulation, leading to B cell differentiation including Ig class switching. Nevertheless, remarkable synergistic 
induction of IB- protein was observed in both A20 and splenic B cells. This observation suggests functional 
significance of the synergistic induction, which is evident in IB--dependent cytotoxic T-lymphocyte-associated 
protein 4 (Ctla4) induction in splenic B cells. The quantitative difference at the mRNA and protein levels of the 
synergistic induction of IB- indicate that mRNA translation efficiency may be up-regulated by co-stimulation of 
BCR and TLR9 in splenic B cells. Because synergistic induction of IB- mRNA was not prominent, 
post-transcriptional regulation of IB- is likely to be strongly activated by co-stimulation of BCR and TLR9. 
Synergy was not observed by TLR2/1 stimulation, indicating the specificity of TLR9. As TLR9 is localized in the 
endosome, modulation of subcellular localization of TLR9 by BCR may underlie the specificity of the synergy 
(32). 
In addition to NF-B-mediated transcriptional activation, BCR-mediated post-transcriptional activation 
of IB- was suppressed by co-engagement of FcRIIB. Co-ligation of BCR and FcRIIB recruits the inositol 
phosphatase SHIP to ITIM in the cytoplasmic region of FcRIIB (20, 33). FcRIIB signals suppressed 
NF-B-mediated transcriptional activation and BCR-mediated mRNA stabilization of IB-. This finding is the 
first example of FcRIIB-mediated suppression of a post-transcriptional mechanism.  
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Suppression by FcRIIB was specific to BCR induction of IB-, but not TLR. This is consistent with 
the SHIP-mediated suppressive effects of FcRIIB observed for PI3K-dependent BCR activation, but not for TLR 
activation, which does not require PI3K activity. Because FcRIIB deficiency is associated with onset of systemic 
lupus erythematosus, FcRIIB-mediated suppression of IB- expression may prevent the development of 
autoimmune diseases. 
Synergistic induction by BCR and TLR9, and suppression by FcRIIB indicated that IB- induction is 
tightly regulated by interactions between these three receptors. Signals generated by microbial stimulation of TLRs 
and specific antigen recognition by BCR upon infection are integrated and modulate B cell functions (1). 
Therefore, the synergistic induction of IB- is noteworthy in both physiological and pathological contexts. 
Co-engagement of BCR and TLR9 in response to chromatin-containing immune complexes is implicated in 
autoimmune B cell activation in systemic autoimmune diseases (34, 35). Interestingly, suppression by FcRIIB 
was not observed in the synergistic induction of IB- by BCR and TLR9, strongly suggesting that the effect of 
BCR in the synergistic induction does not require PI3K-dependent transcriptional or post-transcriptional activation. 
This may be the molecular basis of inability of FcRIIB to suppress detrimental activation by 
chromatin-containing immune complexes. 
Although further studies are required to elucidate the role of IB- in B cells, its role in the induction of 
cytokines such as IL-10 and TNF- suggests it may be involved in the regulation of B cell functions, such as 
regulatory B cells (36). Studies using IB- deficient mice are currently ongoing in my laboratory. Investigations 
on the role of IB- in B cells will provide new insights into the pathogenesis of autoimmune diseases and 
hopefully provide novel targets for the development of new diagnostics and therapeutics. 
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CONCLUSIONS 
 
In this study, I showed that transcriptional and post-transcriptional regulation control the induction of 
IB- via BCR or TLR stimulation in B cells. As in TLR stimulation, NF-B is a key regulator for the 
transcriptional activation of IB- in BCR stimulation. In addition, BCR stimulation stabilizes IB- mRNA via 
cis-element in the 3’-UTR of IB- mRNA. This post-transcriptional regulation of IB- was not inhibited by 
proteasome inhibitors, which suppress NF-B. These data suggested that transcriptional regulation and 
post-transcriptional regulation are controlled by different pathways. The inhibitory receptor FcRIIB suppresses 
the induction of IB- in response to BCR, but not TLR, stimulation. In addition, PI3K dependency of IB- 
induction differs between TLR and BCR stimulation. Thus, these results suggested that two signaling pathways are 
different. Interestingly, co-stimulation of BCR and TLR9, but not TLR2, synergistically induce IB- and this 
synergy is not inhibited by co-engagement of FcRIIB. This escape mechanism of IB- induction from 
FcRIIB-mediated inhibition may contribute a foundation for pathogenesis of autoimmunity. Finally I showed that 
IB- control several gene expression including IL-10 and CTLA-4 upon BCR or TLR stimulation. These results 
suggested that an important role of IB- in B cell activation.
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FIGURE LEGENDS 
 
FIGURE 1. Induction of IB- upon stimulation of BCR or TLR. (A) Mouse splenocytes were stimulated 
with 20 g/ml F(ab')2 fragment of anti-mouse IgM (IgM), 100 ng/ml LPS, 1 M PMA and 1 M ionomycin 
(PMA/Io) for 1 h. A20 or IIA1.6 cells were stimulated with 25 g/ml F(ab')2 fragment or 50 g/ml intact IgG 
of anti-mouse IgG for 1 h. Total RNA was extracted and expression of mRNAs for IB-, IB-, and -actin 
were examined by northern blot analysis. (B-D) A20 cells were stimulated with 10 g/ml F(ab')2 fragment or 
20 g/ml intact IgG of anti-mouse IgG, or 1 M CpG ODN for the indicated times. Expression of mRNAs for 
IB-, IB-, and GAPDH were quantitated by real-time RT-PCR (B and C). Copy numbers of IB- or 
IB- mRNA per 1,000 copies of GAPDH mRNA are shown. Data represent the mean ± S.E. of duplicate 
samples representative of at least two independent experiments. The cells were lysed and analyzed by 
immunoblotting with anti-IB- or anti--actin antibody (D). 
 
FIGURE 2. Activation of the IB- promoter upon stimulation of BCR. (A) A20 cells were transfected 
with pGL3-basic (None), pNfkbiz(-1,725)-Luc (IB-), or pELAM1-Luc (ELAM1) together with 
pEF6/V5-His A and selected with blasticidin. Cells were stimulated with 10 g/ml F(ab')2 fragment of 
anti-mouse IgG for 3 h and luciferase activity was measured. (B) A20 cells transfected with pGL3-basic 
(None), pNfkbiz(-786)-Luc, pNfkbiz(-786(B1M))-Luc, pNfkbiz(-786(B2M))-Luc, or 
pNfkbiz(-786(B3M))-Luc, were stimulated as in (A). Data represent the mean ± S.E. of duplicate samples 
representative of at least two independent experiments. 
 
FIGURE 3. Post-transcriptional activation of IB- mRNA upon stimulation of BCR. (A) Schematic 
illustrations of the reporter plasmids. (B-E) A20 cells were transfected with pGL4.12-SV40-[luc2CP] (None), 
pGL4.12-SV40-[luc2CP]-Nfkbiz-Full, -Reverse, or After pA (B and C) or pGL4.12-SV40-[luc2CP] (None), 
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pGL4.12-SV40-[luc2CP]-Nfkbiz-3'-UTR, or -165nt (D and E) together with pEF6/V5-His A and selected with 
blasticidin. Luciferase activity before (B and D) or after stimulation with 10 g/ml F(ab')2 fragment of 
anti-mouse IgG for the indicated times (C and E) was measured. Data represent the mean ± S.E. of duplicate 
samples representative of at least two independent experiments. 
 
FIGURE 4. Stabilization of IB- mRNA upon stimulation of BCR. (A and B) A20 cells stably transfected 
with pEF-Tet-off and pTRE2-Luc (A) or pTRE2-Luc-Nfkbiz-3'-UTR (B) were treated with 2 g/ml Dox 
together with or without 10 g/ml F(ab')2 fragment of anti-mouse IgG. Total RNA was extracted and mRNAs 
for luciferase and GAPDH were quantitated by real-time RT-PCR. Relative luciferase mRNA expression levels 
normalized to GAPDH are shown. Data represent the mean ± S.E. of duplicate samples representative of at 
least two independent experiments. 
 
FIGURE 5. Proteasome inhibitors inhibit NF-B-mediated transcriptional activation, but not 
post-transcriptional activation of IB-. A20 cells (A) or RAW264.7 cells (B and C) were transfected with 
pGL3-basic (None), pELAM1-Luc (ELAM1), pNfkbiz(-1,725)-Luc (IB-), or 
pGL4.12-SV40-[luc2CP]-Nfkbiz-165nt (165nt) together with pEF6/V5-His A or pcDNA3 and selected with 
blasticidin or G418. Stably transfected clones were established with pELAM1-Luc and 
pGL4.12-SV40-[luc2CP]-Nfkbiz-165nt transfectants. Cells were pre-treated with the indicated concentrations 
of MG-132 or lactacystin for 30 min, stimulated with 10 g/ml F(ab')2 fragment of anti-mouse IgG for 3 h (A) 
or with 100 ng/ml LPS for 4 h (B) or 2 h (C), and luciferase activity was measured. Data represent the mean ± 
S.E. of duplicate samples representative of at least two independent experiments. 
 
FIGURE 6. FcRIIB co-engagement inhibits both transcriptional and post-transcriptional activation of 
IB-. (A) A20 cells were transfected with pGL3-basic (None), pELAM1-Luc (ELAM1), pNfkbiz(-1,725)-Luc 
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(IB-) together with pEF6/V5-His A and selected with blasticidin. Cells were stimulated with 10 g/ml 
F(ab')2 fragment or 20 g/ml intact IgG of anti-mouse IgG for 3 h and luciferase activity was measured. (B) 
A20 cells transfected with pTet-off-pTRE2-Luc-IB--3'-UTR were treated with 2 g/ml Dox with or without 
10 g/ml F(ab')2 fragment or 20 g/ml intact IgG of anti-mouse IgG. Total RNA was extracted and mRNAs for 
luciferase and GAPDH were quantitated by real-time RT-PCR. Relative luciferase mRNA expression levels 
normalized to GAPDH are shown. (C and D) A20 cells transfected with pGL4.12-SV40-[luc2CP] (C) or 
pGL4.12-SV40-[luc2CP]-Nfkbiz-165nt (D) were stimulated with 20 g/ml F(ab')2 fragment or 40 g/ml intact 
IgG of anti-mouse IgG for the indicated periods with or without pre-treatment with 4 g/ml 2.4G2 for 30 min. 
Then, cells were lysed and luciferase activity was measured. Data represent the mean ± S.E. of duplicate 
samples representative of at least two independent experiments. 
 
FIGURE 7. IB- induction by engagement of BCR, TLR, and FcRIIB. (A-H) A20 cells (A-D, and G) or 
purified splenic B cells (E, F, and H) were stimulated with 20 g/ml F(ab')2 fragment or 40 g/ml intact IgG of 
anti-mouse Ig, 1 M CpG ODN (A, B, and G), 30 nM CpG ODN (E, F, and H; +), 100 nM CpG ODN (E, F, 
and H; ++), or 100 ng/ml Pam3CSK4 (C and D) alone or in combination for 1 h. Total RNA was extracted and 
mRNAs for IB-, IB-, and GAPDH were quantitated by real-time RT-PCR. Copy numbers of IB- or 
IB- mRNA per 1,000 copies of GAPDH mRNA are shown. Data represent the mean ± S.E. of duplicate 
samples representative of at least two independent experiments (A-F). The cells were lysed and analyzed by 
immunoblotting with anti-IB- or anti--actin antibody (G and H). (I and J) A20 cells were pre-treated with 
the indicated concentrations of LY294002 for 30 min, and stimulated with 10 g/ml F(ab')2 fragment of 
anti-mouse IgG (I, BCR) or 1 M CpG ODN (J, TLR9) for 1 h. Total RNA was extracted and mRNAs for 
IB- and -actin were quantitated by real-time RT-PCR. Copy numbers of IB- mRNA per 1,000 copies of 
-actin mRNA are shown. Data represent the mean ± S.E. of duplicate samples representative of at least two 
independent experiments. 
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FIGURE 8. Gene expression in stimulated IB--deficient B cells. Purified splenic B cells from 
IB--deficient mice (KO) or wild type (WT) littermate controls were stimulated with 20 g/ml F(ab')2 
fragment of anti-mouse IgM (A, C¸ and D), 40 g/ml intact IgG of anti-mouse IgM (D), 50 nM CpG ODN (B, 
and C) or 100 nM CpG ODN (D) alone or in combination for 24 h (A, C, and D) or 4 h (B). Total RNA was 
extracted and mRNAs for indicated genes and -actin were quantitated by real-time RT-PCR. Relative mRNA 
expression levels were normalized to -actin (A-C). IL-10 and TNF- in the culture supernatant were measure 
by ELISA (D). Data represent the mean ± S.E. of duplicate samples representative of at least two independent 
experiments. N.D., not detected. 
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